drugset / Trial / NCT00003711

Combination Chemotherapy in Treating Patients With Metastatic Solid Tumors

NCT00003711

Phase 1 Completed San Antonio Cancer Institute
Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of combination chemotherapy with pemetrexed disodium and irinotecan in treating patients who have metastatic solid tumors.

Timeline

Start
1997-09
Primary completion
Completion
2004-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Irinotecan Small molecule Intravenous
Subject Pemetrexed Small molecule Intravenous